G. E. Hanks, T. F. Pajak, A. Porter, D. Grignon, H. Brereton et al., Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02, J Clin Oncol Off J Am Soc Clin Oncol, vol.21, issue.21, pp.3972-3980, 2003.

M. Bolla, T. M. De-reijke, G. Van-tienhoven, A. Van-den-bergh, J. Oddens et al., Duration of androgen suppression in the treatment of prostate cancer, N Engl J Med, vol.360, issue.24, pp.2516-2543, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00492521

S. B. Edge and C. C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM, Ann Surg Oncol, vol.17, issue.6, pp.1471-1475, 2010.

A. V. D'amico, R. Whittington, S. B. Malkowicz, D. Schultz, K. Blank et al., Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer, JAMA, vol.280, issue.11, pp.969-74, 1998.

M. De-rooij, E. Hamoen, J. A. Witjes, J. O. Barentsz, and M. M. Rovers, Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis, Eur Urol, vol.70, issue.2, pp.233-278, 2016.

A. Morlacco, V. Sharma, B. R. Viers, L. J. Rangel, R. E. Carlson et al., The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy, Eur Urol, vol.71, issue.5, pp.701-705, 2017.

M. E. Shukla, C. Yu, C. A. Reddy, K. L. Stephans, E. A. Klein et al., Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database, Clin Genitourin Cancer, vol.13, issue.1, pp.17-21, 2015.

F. Cornud, T. Flam, L. Chauveinc, K. Hamida, Y. Chrétien et al., Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results, Radiology, vol.224, issue.1, pp.203-213, 2002.

R. Johnston, L. Wong, A. Warren, N. Shah, and D. Neal, The role of 1.5 Tesla magnetic resonance imaging in staging prostate cancer, ANZ J Surg, vol.83, issue.4, pp.234-242, 2013.

J. S. Brajtbord, H. J. Lavery, F. Nabizada-pace, P. Senaratne, and D. B. Samadi, Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer, BJU Int, vol.107, issue.9, pp.1419-1443, 2011.

S. A. Siddiqui, S. A. Boorjian, M. L. Blute, L. J. Rangel, E. J. Bergstralh et al., Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer, BJU Int, vol.107, issue.3, pp.383-391, 2011.

W. S. Jang, C. Y. Yoon, K. H. Kim, Y. J. Kang, S. Shin et al., Prognostic Significance of Vas Deferens Invasion After Radical Prostatectomy in Patients with Pathological Stage T3b Prostate Cancer, Ann Surg Oncol, vol.24, issue.4, pp.1143-1152, 2017.

C. Bastide, D. Rossi, E. Lechevallier, F. Bladou, D. Barriol et al., Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy? BJU Int, vol.109, pp.525-530, 2012.

H. J. Lee, J. Han, D. H. Lee, J. K. Nam, T. N. Kim et al., Does bilateral seminal vesicle invasion at radical prostatectomy predict worse prognosis than unilateral invasion among patients with pT3b prostate cancers?, Int J Urol Off J Jpn Urol Assoc, vol.23, issue.9, pp.758-63, 2016.

A. Kristiansen, L. Drevin, B. Delahunt, H. Samaratunga, D. Robinson et al., Prognostic significance and biopsy characteristics of prostate cancer with seminal vesicle invasion on radical prostatectomy: a nationwide population-based study. Pathology (Phila), vol.49, pp.715-735, 2017.

J. K. Ryu, K. Winter, J. M. Michalski, J. A. Purdy, A. M. Markoe et al., Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy), Int J Radiat Oncol Biol Phys, vol.54, issue.4, pp.1036-1082, 2002.

L. B. Marks, E. D. Yorke, A. Jackson, R. K. Ten-haken, L. S. Constine et al., Use of normal tissue complication probability models in the clinic, Int J Radiat Oncol Biol Phys, vol.76, issue.3, pp.10-19, 2010.

V. Beckendorf, S. Guerif, L. Prisé, E. Cosset, J. Bougnoux et al., 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial, Int J Radiat Oncol Biol Phys, vol.80, issue.4, pp.1056-63, 2011.

M. J. Zelefsky, E. J. Levin, M. Hunt, Y. Yamada, A. M. Shippy et al., Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensitymodulated radiotherapy for localized prostate cancer, Int J Radiat Oncol Biol Phys, vol.70, issue.4, pp.1124-1133, 2008.

O. Cahlon, M. Hunt, and M. J. Zelefsky, Intensity-modulated radiation therapy: supportive data for prostate cancer, Semin Radiat Oncol, vol.18, issue.1, pp.48-57, 2008.

D. E. Spratt, X. Pei, J. Yamada, M. A. Kollmeier, B. Cox et al., Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer, Int J Radiat Oncol Biol Phys, vol.85, issue.3, pp.686-92, 2013.

F. N. Soylu, Y. Peng, Y. Jiang, S. Wang, C. Schmid-tannwald et al., Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging, Radiology, vol.267, issue.3, pp.797-806, 2013.

C. J. Mcmahon, N. M. Rofsky, and I. Pedrosa, Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging, Radiology, vol.254, issue.1, pp.31-46, 2010.

R. De-crevoisier, P. Pommier, I. Latorzeff, O. Chapet, B. Chauvet et al.,

, Cancer Radiother J Soc Francaise Radiother Oncol, pp.200-209, 1920.

J. M. Michalski, J. Moughan, J. Purdy, W. Bosch, D. W. Bruner et al., Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial, JAMA Oncol, 2018.

L. B. Marks, E. D. Yorke, A. Jackson, R. K. Ten-haken, L. S. Constine et al., The Use of Normal Tissue Complication Probability (NTCP) Models in the Clinic, Int J Radiat Oncol Biol Phys, vol.76, pp.10-19, 1930.

M. Schemper and T. L. Smith, A note on quantifying follow-up in studies of failure time, Control Clin Trials, vol.17, issue.4, pp.343-349, 1996.

M. Roach, G. Hanks, H. Thames, P. Schellhammer, W. U. Shipley et al., Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference, Int J Radiat Oncol Biol Phys, vol.65, issue.4, pp.965-74, 2006.

M. J. Zelefsky, M. Kollmeier, B. Cox, A. Fidaleo, D. Sperling et al., Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer, Int J Radiat Oncol Biol Phys, vol.84, issue.1, pp.125-134, 2012.

D. E. Spratt, X. Pei, J. Yamada, M. A. Kollmeier, B. Cox et al., Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer, Int J Radiat Oncol Biol Phys, vol.85, issue.3, pp.686-92, 2013.

S. A. Vora, W. W. Wong, S. E. Schild, G. A. Ezzell, P. E. Andrews et al., Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer, J Urol, vol.190, issue.2, pp.521-527, 2013.

J. M. Michalski, Y. Yan, D. Watkins-bruner, W. R. Bosch, K. Winter et al., Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial, Int J Radiat Oncol Biol Phys, vol.87, issue.5, pp.932-940, 2013.

M. Van-der-burgt, L. Bergsma, J. De-vries, F. J. Pos, R. Kalisvaart et al., Impact of tumour invasion on seminal vesicles mobility in radiotherapy of prostate cancer, Radiother Oncol J Eur Soc Ther Radiol Oncol, vol.117, issue.2, pp.283-290, 2015.

J. Liang, Q. Wu, and D. Yan, The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer, Int J Radiat Oncol Biol Phys, vol.73, issue.3, pp.935-978, 2009.

N. N. Stone, V. M. Skouteris, and R. G. Stock, Biopsy and implantation of the seminal vesicles, Brachytherapy, vol.11, issue.5, pp.334-374, 2012.

D. Rades, R. Schwarz, M. Todorovic, H. Thurmann, M. Graefen et al., Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer, Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al, vol.183, issue.7, pp.398-402, 2007.

H. Tsumura, H. Ishiyama, K. Tabata, H. Katsumata, M. Kobayashi et al., Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapy. The Prostate, vol.77, pp.1520-1527, 2017.

P. G. Koutrouvelis, J. Gillenwater, N. Lailas, F. Hendricks, S. Katz et al., High and intermediate risk prostate cancer treated with three-dimensional computed tomography-guided brachytherapy: 2-8-year follow-up, Radiother Oncol J Eur Soc Ther Radiol Oncol, vol.67, issue.3, pp.303-311, 2003.

M. Moschini, V. Sharma, G. Gandaglia, P. Dell'oglio, N. Fossati et al., Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy, BJU Int, vol.120, issue.1, pp.69-75, 2017.

M. J. Pagano, M. J. Whalen, D. J. Paulucci, B. N. Reddy, J. T. Matulay et al., Predictors of biochemical recurrence in pT3b prostate cancer after radical prostatectomy without adjuvant radiotherapy. The Prostate, vol.76, pp.226-260, 2016.

G. P. Swanson, B. Goldman, C. M. Tangen, J. Chin, E. Messing et al., The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794, J Urol, vol.180, issue.6, pp.2453-2457, 2008.

L. Salomon, A. G. Anastasiadis, C. W. Johnson, J. M. Mckiernan, E. T. Goluboff et al., Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression, Urology, vol.62, issue.2, pp.304-313, 2003.

S. J. Freedland, W. J. Aronson, J. C. Presti, C. L. Amling, M. K. Terris et al., Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy. Cancer, vol.100, pp.1633-1641, 2004.

M. V. Pilepich, K. Winter, C. A. Lawton, R. E. Krisch, H. B. Wolkov et al., Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31, Int J Radiat Oncol Biol Phys, vol.61, issue.5, pp.1285-90, 2005.

E. M. Horwitz, K. Bae, G. E. Hanks, A. Porter, D. J. Grignon et al., Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer, J Clin Oncol Off J Am Soc Clin Oncol, vol.26, issue.15, pp.2497-504, 2008.

A. Widmark, O. Klepp, A. Solberg, J. Damber, A. Angelsen et al., Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial, Lancet Lond Engl, vol.373, issue.9660, pp.301-309, 2009.

M. Bolla, G. Van-tienhoven, W. P. Dubois, J. B. Mirimanoff, R. Storme et al., External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study, Lancet Oncol, vol.11, issue.11, pp.1066-73, 2010.

N. Mottet, M. Peneau, J. Mazeron, V. Molinie, and P. Richaud, Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial, Eur Urol, vol.62, issue.2, pp.213-222, 2012.

I. S. Dayes, S. Parpia, J. Gilbert, J. A. Julian, I. R. Davis et al., Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate, Int J Radiat Oncol Biol Phys, vol.99, issue.1, pp.90-93, 201701.

S. Rodda, S. Tyldesley, W. J. Morris, M. Keyes, R. Halperin et al., ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High-and IntermediateRisk Prostate Cancer, Int J Radiat Oncol Biol Phys, vol.98, issue.2, pp.286-95, 201701.

S. Rodda, W. J. Morris, J. Hamm, and G. Duncan, ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High-and Intermediate-Risk Prostate Cancer, Int J Radiat Oncol Biol Phys, vol.98, issue.3, pp.581-590, 201701.

P. J. Hoskin, A. M. Rojas, P. J. Bownes, G. J. Lowe, P. J. Ostler et al., Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer, Radiother Oncol J Eur Soc Ther Radiol Oncol, vol.103, issue.2, pp.217-239, 2012.

A. Amini, B. Jones, M. W. Jackson, N. Yeh, T. V. Waxweiler et al., Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base, J Urol, vol.195, issue.5, pp.1453-1461, 2016.

R. D. Ennis, L. Hu, S. N. Ryemon, J. Lin, and M. Mazumdar, Brachytherapy-Based Radiotherapy and Radical Prostatectomy Are Associated With Similar Survival in High-Risk Localized Prostate Cancer, J Clin Oncol Off J Am Soc Clin Oncol, vol.36, issue.12, pp.1192-1200, 2018.

N. N. Stone, R. G. Stock, D. Parikh, P. Yeghiayan, and P. Unger, Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate, J Urol, vol.160, issue.5, pp.1722-1728, 1998.

T. A. Masterson, J. A. Pettus, R. G. Middleton, and R. A. Stephenson, Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status, Urology, vol.66, issue.1, pp.152-157, 2005.

M. Sofer, M. Savoie, S. S. Kim, F. Civantos, and M. S. Soloway, Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion, J Urol, vol.169, issue.1, pp.153-159, 2003.

C. Fiorino, R. Valdagni, T. Rancati, and G. Sanguineti, Dose-volume effects for normal tissues in external radiotherapy: Pelvis. Radiother Oncol, vol.93, pp.153-67, 2009.